Cargando…

Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation

PURPOSE: The aim of this study is to evaluate changes in sleep disturbance following treatment of overactive bladder with sacral neuromodulation. MATERIALS AND METHODS: This is a sub-analysis of data collected from an institutional review board approved retrospective cohort study evaluating women wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanderson, Derrick J., Gevelinger, Matthew, Jaworski, Elaine, Doyle, Paula J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2020
Materias:	Innovations in Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052411/ https://www.ncbi.nlm.nih.gov/pubmed/32158975 http://dx.doi.org/10.4111/icu.2020.61.2.231

Ejemplares similares

A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder
por: Al-Azzawi, Issam S., et al.
Publicado: (2020)

Is Sacral Neuromodulation a Treatment Option for Primary Bladder Neck Obstruction?
por: Alzahrani, Ibrahim, et al.
Publicado: (2022)

Sacral Neuromodulation for Bladder Atony – A Case Report()
por: Sujka, Joseph, et al.
Publicado: (2014)

Friction underwear for ease of pulling down in elderly patients with overactive bladder: A prospective randomized control trial
por: You, Jae Hyung, et al.
Publicado: (2019)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

Sacral neuromodulation in overactive bladder: a review and current perspectives
por: Sukhu, Troy, et al.
Publicado: (2016)

Sacral Neuromodulation in a Pregnant Patient With Fowler's Syndrome: A Case Report
por: Alghazwani, Yahia, et al.
Publicado: (2020)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

Unsuccessful Progression of Sacral Neuromodulation From the Evaluation to the Implantation Stage: A Single-Center Experience
por: Alghafees, Mohammad A, et al.
Publicado: (2021)

Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance
por: Poole, Ruth Louise, et al.
Publicado: (2021)

Effects of Acute Sacral Neuromodulation at Different Frequencies on Bladder Overactivity in Pigs
por: Li, Xing, et al.
Publicado: (2017)

Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study
por: Kaaki, Bilal, et al.
Publicado: (2020)

Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
por: Zhang, Yaoguang, et al.
Publicado: (2021)

Editorial Comment: Sacral neuromodulation for neurogenic Lower Urinary Tract Dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2023)

Effects of Acute Sacral Neuromodulation at Different Pulse Widths on Bladder Overactivity in Pigs
por: Cong, Huiling, et al.
Publicado: (2019)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

Editorial Comment: Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function
por: Riccetto, Cássio L. Z.
Publicado: (2020)

Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report
por: Shen, Jianwu, et al.
Publicado: (2019)

Feasibility of the Lilium α-200 portable ultrasound bladder scanner for accurate bladder volume measurement
por: Majima, Tsuyoshi, et al.
Publicado: (2020)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study
por: Wyndaele, J-J, et al.
Publicado: (2009)

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison
por: Freemantle, Nick, et al.
Publicado: (2016)

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients
por: Reekmans, Mathias, et al.
Publicado: (2021)

Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence
por: Wyman, J F, et al.
Publicado: (2009)

Risk factors associated with the progression of overactive bladder among patients with type 2 diabetes
por: Zhu, Yiyi, et al.
Publicado: (2019)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Potential benefits of diagnosis and treatment on health outcomes among elderly people with symptoms of overactive bladder
por: Lee, L. K., et al.
Publicado: (2015)

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER
por: Kaplan, S A, et al.
Publicado: (2014)

Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
por: Berthelot, Louis-Paul, et al.
Publicado: (2019)

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
por: Meng, Lingfeng, et al.
Publicado: (2020)

Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters
por: Groenendijk, Ilse M., et al.
Publicado: (2019)

A novel approach to overactive bladder syndrome treatment
por: Szalecki, Paweł
Publicado: (2014)

Mechanism of traditional Chinese medicine in treating overactive bladder
por: Liao, Yuxiang, et al.
Publicado: (2022)

The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
por: Al-Azzawi, Issam S., et al.
Publicado: (2018)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

Refractory Sexual Arousal Subsequent to Sacral Neuromodulation
por: Zoorob, Dani, et al.
Publicado: (2019)

Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis
por: Yang, Guang, et al.
Publicado: (2020)

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria
por: Matsumoto, Seiji, et al.
Publicado: (2013)

Neuromodulation – a therapeutic option for refractory overactive bladder. A recent literature review
por: Szymański, Jacek K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_es6a7testlck56bs3p1lf6m9h9